A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection

Virology

Volumn 318, Issue 1, 2004, Pages 414-419

  Kondo, Takashi ^a,b   McGregor, Martha ^b   Chu, Qili ^c   Chen, Dexiang ^c   Horimoto, Taisuke ^d,e   Kawaoka, Yoshihiro ^b,d,e  

^a EQUINE RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c PowderJect Vaccines Inc   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Epidermal powder immunization; Equine herpesvirus 1; Vaccine

Indexed keywords

DNA VACCINE; FORMALDEHYDE; GLYCOPROTEIN D; HERPES VACCINE; INACTIVATED VACCINE; POWDER VACCINE; SUGAR; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE GUN; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; MOUSE; NONHUMAN; POWDER; PRIORITY JOURNAL; VACCINATION; VIRION; VIRUS INACTIVATION; WILD TYPE;

EQUIDAE; EQUINE HERPESVIRUS 1; HERPESVIRIDAE;

EID: 1242342121     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.09.031     Document Type: Article

References (36)

1. k) mice. Vaccine. 19:2001;895-901.
2. Allen G.P., Bryans J.T. Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus-1 infections. Prog. Vet. Microbiol. Immunol. 2:1986;78-144.
3. Allen G.P., Kydd J.H., Slater J.D., Smith K.C. Advances in understanding of the pathogenesis, epidemiology and immunological control of equine herpesvirus abortion. Wernery U., Wade J.F., Mumford J.A., Kaaden O.R. Proceedings of the Eighth International Conference on Equine Infectious Diseases. 1999;129-146 R&W Publications, Newmarket.
4. Awan A.R., Chong Y.C., Field H.J. The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J. Gen. Virol. 71:1990;1131-1140.
5. Bürki F., Rossmanith W., Nowotny N., Pallan C., Möstl K., Lussy H. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet. Q. 12:1990;80-86.
6. Burrows R., Goodridge D., Denyer M.S. Trials of an inactivated equine herpesvirus 1 vaccine: challenge with a subtype-1 virus. Vet. Rec. 114:1984;369-374.
7. Chen D., Payne L.G. Targeting epidermal Langerhans cells by epidermal powder immunization. Cell Res. 12:2002;97-104.
8. Chen D., Endres R.L., Erickson C.A., Weis K.F., McGregor M.W., Kawaoka Y., Payne L.G. Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza vaccine and protection in mice. Nat. Med. 6:2000;1187-1190.
9. Chen D., Chu Q., Erickson C.A., Endres R.L., Livery C.R., Osorio J., Payne L.G. Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses. J. Virol. 75:2001;11630-11640.
10. Chen D., Erickson C.A., Endres R.L., Periwal S.B., Chu Q., Shu C., Maa Y., Payne L.G. Adjuvantation of epidermal powder immunization. Vaccine. 19:2001;2908-2917.
11. Chen D., Periwal S.B., Larrivee K., Zuleger C., Erickson C.A., Endres R.L., Payne L.G. Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder vaccine. J. Virol. 75:2001;7956-7965.
12. Chen D., Endres R.L., Erickson C.A., Maa Y., Payne L.G. Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity. Vaccine. 20:2002;2671-2679.
13. Chen D., Zuleger C., Chu Q., Maa Y.F., Osorio J., Payne L.G. Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses. AIDS Res. Hum. Retroviruses. 18:2002;715-722.
14. Cornick J., Martens J., Crandel R., McConnell S., Kit S. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses. Can. J. Vet. Res. 54:1990;260-266.
15. Crabb B.S., Studdert M.J. Equine herpesvirus 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Adv. Virus Res. 45:1995;153-190.
16. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11478-11482.
17. Gilkerson J.R., Love D.N., Whalley J.M. A review of equine herpesvirus vaccine: from the traditional to the experimental. Aust. Equine. Vet. 15:1997;27-32.
18. Kobasa D., Rodgeres M.E., Wells K., Kawaoka Y. Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J. Virol. 71:1997;6706-6713.
19. Maa Y., Zhao L., Payne L.G., Chen D. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application. J. Pharm. Sci. 92:2003;319-332.
20. Matsumura T., Kondo T., Sugita S., Damiani A.M., O'Callaghan D.J., Imagawa H. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses. Virology. 242:1998;68-79.
21. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-199.
22. Osorio J.E., Zuleger C.L., Burger M., Chu Q., Payne L.G., Chen D. Immune responses to hepatitis B surface antigen following epidermal powder immunization. Immunol. Cell Biol. 81:2003;52-58.
23. Packiarajah P., Walker C., Gilkerson J., Whalley J.M., Love D.N. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice. Vet. Microbiol. 61:1998;261-278.
24. Patel J.R., Földi J., Bateman H., Williams J., Didlick S., Stark R. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4. Vet. Microbiol. 92:2003;1-17.
25. Patel J.R., Bateman H., Williams J., Didlick S. Derivation and characterization of a live equid herpesvirus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1. Vet. Microbiol. 91:2003;23-39.
26. Ruitenberg K.M., Walker C., Wellington J.E., Love D.N., Whalley J.M. Potential of DNA-mediated vaccination for equine herpesvirus 1. Vet. Microbiol. 68:1999;35-48.
27. Ruitenberg K.M., Love D.N., Gilkerson J.R., Wellington J.E., Whalley J.M. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody. Vet. Microbiol. 76:2000;117-127.
28. Ruitenberg K.M., Walker C., Love D.N., Wellington J.E., Whalley J.M. A prime-boost immunization strategy with DNA and recombinant baculovirus- expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naive and infection-primed mice. Vaccine. 18:2000;1367-1373.
29. Ruitenberg K.M., Gilkerson J.R., Wellington J.E., Love D.N., Whalley J.M. Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease. Virus Res. 79:2001;125-135.
30. Slater J.D., Gibson J.S., Field J.H. Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals. J. Gen. Virol. 74:1993;819-828.
31. Slater J. D., Borchers K., Thackray A. M., Field H. J. The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. J. Gen. Virol. 75:1994;2007-2016.
32. k) murine model. Virus Res. 50:1997;159-173.
33. Tewari D., Whalley J.M., Love D.N., Field H.J. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J. Gen. Virol. 75:1994;1735-1741.
34. Tewari D., Nair S.V., De Ungria M.C., Lawrence G.L., Hayden M., Love D.N., Field H.J., Whalley J.M. Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model. Arch. Virol. 140:1995;789-797.
35. Walker C., Love D.N., Whalley J.M. Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse model: a review. Vet. Microbiol. 68:1999;3-13.
36. Walker C., Ruitenberg K.M., Love D.N., Whalley J.M. Immunization of BALB/c mice with DNA encoding equine herpesvirus 1 (EHV-1) glycoprotein D affords partial protection in a model of EHV-1-induced abortion. Vet. Microbiol. 76:2000;211-220.